Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts (TheraVACCS)
Prophylactic Vaccines as Therapy: Prevention of Recurrence of Extensive Genital Warts
Sponsor: University of Pretoria
This PHASE3 trial investigates Genital Warts and is currently completed. University of Pretoria leads this study, which shows 13 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE3
-
Dec 2025 — Feb 2026 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Aug 2025 — Dec 2025 [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — Aug 2025 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
▶ Show 8 earlier versions
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Apr 2023 — Jun 2024 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Apr 2021 — Apr 2023 [monthly]
Recruiting PHASE3
-
Jan 2021 — Apr 2021 [monthly]
Recruiting PHASE3
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Nov 2018 — Mar 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pretoria
- University of Stellenbosch
For direct contact, visit the study record on ClinicalTrials.gov .